Resource Brochure

Upper Explosive Limit (%) Not Applicable Surface Tension (dyn/cm or mN/m) Not Applicable Lower Explosive Limit (%) Not Applicable Volatile Component (%vol) Not Available Vapour pressure (kPa) Not Applicable Gas group Not Available Solubility in water (g/L) Immiscible pH as a solution(1%) Not Applicable Vapour density (Air = 1) Not Applicable VOC g/L Not Available SECTION 10 STABILITY AND REACTIVITY Reactivity See section 7 Chemical stability Unstable in the presence of incompatible materials. Product is considered stable. Hazardous polymerisation will not occur. Possibility of hazardous reactions See section 7 Conditions to avoid See section 7 Incompatible materials See section 7 Hazardous decomposition products See section 5 SECTION 11 TOXICOLOGICAL INFORMATION Information on toxicological effects Inhaled The material is not thought to produce respiratory irritation (as classified by EC Directives using animal models). Nevertheless inhalation of dusts, or fumes, especially for prolonged periods, may produce respiratory discomfort and occasionally, distress. Acute silicosis occurs under conditions of extremely high silica dust exposure particularly when the particle size of the dust is small. It differs greatly from classical silicosis both clinically and pathologically. Ingestion The material has NOT been classified by EC Directives or other classification systems as "harmful by ingestion". This is because of the lack of corroborating animal or human evidence. The material may still be damaging to the health of the individual, following ingestion, especially where pre-existing organ (e.g liver, kidney) damage is evident. Present definitions of harmful or toxic substances are generally based on doses producing mortality rather than those producing morbidity (disease, ill-health). Skin Contact The material is not thought to produce adverse health effects or skin irritation following contact (as classified by EC Directives using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable gloves be used in an occupational setting. Eye Limited evidence exists, or practical experience suggests, that the material may cause eye irritation in a substantial number of individuals and/or is expected to produce significant ocular lesions which are present twenty-four hours or more after instillation into the eye(s) of experimental animals. Repeated or prolonged eye contact may cause inflammation characterised by temporary redness (similar to windburn) of the conjunctiva (conjunctivitis); temporary impairment of vision and/or other transient eye damage/ulceration may occur. Chronic Harmful: danger of serious damage to health by prolonged exposure through inhalation. Serious damage (clear functional disturbance or morphological change which may have toxicological significance) is likely to be caused by repeated or prolonged exposure. As a rule the material produces, or contains a substance which produces severe lesions. Such damage may become apparent following direct application in subchronic (90 day) toxicity studies or following sub-acute (28 day) or chronic (two-year) toxicity tests. EssaStone TOXICITY IRRITATION Not Available Not Available silica crystalline - quartz TOXICITY IRRITATION Inhalation (human) LCLo: 0.3 mg/m3/10Y Y Inhalation (human) TCLo: 16 mppcf*/8H/17.9 Inhalation (rat) TCLo: 50 mg/m3/6H/71W Not Available Not Available styrene TOXICITY IRRITATION Inhalation (Human) LCLo: 10000 ppm/30 m Eye (rabbit): 100 mg/24h - moderate Inhalation (Mouse) LC50: 9500 mg/m3/4h Skin (rabbit): 500 mg - mild Inhalation (Rabbit) LC: 4000 ppm/4h Inhalation (Rat) LC50: 24000 mg/m3/4h Intraperitoneal (Mouse) LD50: 660 mg/kg Intraperitoneal (Rat) LD50: 898 mg/kg Intravenous (Mouse) LD50: 90 mg/kg Oral (Mouse) LD50: 316 mg/kg Oral (Rat) LD50: 2650 mg/kg Not Available Not Available Not available. Refer to individual constituents. Chemwatch: 22-9931 Version No: 5.1.1.1 Page 5 of 7 EssaStone Issue Date: 11/03/2014 Print Date: 15/06/2014 Continued...

RkJQdWJsaXNoZXIy MTE4OTI4